Ocular drug delivery systems: glaucoma patient perceptions from a German university hospital eye clinic

被引:2
作者
Weber, Constance [1 ]
Quintin, Philipp [1 ]
Holz, Frank G. [1 ]
Fea, Antonio [2 ]
Mercieca, Karl [1 ]
机构
[1] Univ Bonn, Dept Ophthalmol, Ernst Abbe Str 2, D-53117 Bonn, Germany
[2] Univ Turin, Dept Ophthalmol, Turin, Italy
关键词
Ocular drug delivery devices; Stents; Glaucoma medication; Patient adherence; Eyedrops; SINGAPOREAN CHINESE; SUSTAINED-RELEASE; CONTACT-LENSES; MEDICATION; ADHERENCE; SUBCONJUNCTIVAL; ACCEPTANCE; BELIEFS;
D O I
10.1007/s00417-023-06248-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose This study aimed to report on glaucoma patients' beliefs and illness perceptions and to investigate their opinion on ocular drug delivery devices (ODD).Methods We performed a cross-sectional study in a large tertiary-referral outpatient glaucoma clinic, with 102 patients. Validated anonymized questionnaires were used. We investigated the awareness and acceptance regarding ODD (contact lenses (CLs), punctal plugs (PPs), subconjunctival implants, anterior chamber (AC) injections, and drug-emitting stents) and looked at factors that could influence a patient's decision for having an ODD.Results Sixty-three patients (61.8%) confirmed they would rather have ODD than keep their eye-drops (38.2%). The most important factors influencing their decision were effectiveness and long-lasting effect. A large proportion of patients reported a preference for CLs (48.0%), PPs (52.9%), or drug-emitting stents (44.1%). When comparing patients who preferred ODD (group-1) versus eye-drops (group-2), significantly more patients in group-1 were worried (p < 0.001) or felt disrupted (p < 0.001) by their use of eye-drops. A significantly greater share of patients in group-1 showed acceptance towards CLs (60.3% vs. 38.5%; p = 0.032), AC injections (38.1% vs. 12.8%, p = 0.006), or drug-emitting stents (54% vs. 28.2%, p = 0.023), whilst there were no significant differences regarding the acceptance of PPs (p = 0.363) or subconjunctival implants (p = 0.058).Conclusion ODD for the treatment of glaucoma were broadly deemed acceptable by patients in this study. Effectiveness and long-lasting effect were the most important factors for a decision towards having an ODD. The majority of patients who preferred an ODD felt severely affected by their disease and were negatively influenced by their glaucoma medication intake.
引用
收藏
页码:545 / 556
页数:12
相关论文
共 32 条
[1]   Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2) [J].
Bacharach, Jason ;
Tatham, Andrew ;
Ferguson, Gloria ;
Belalcazar, Sandra ;
Thieme, Hagen ;
Goodkin, Margot L. ;
Chen, Michelle Y. ;
Guo, Qiang ;
Liu, Jeen ;
Robinson, Michael R. ;
Bejanian, Marina ;
Wirta, David L. .
DRUGS, 2021, 81 (17) :2017-2033
[2]   The Brief Illness Perception Questionnaire [J].
Broadbent, Elizabeth ;
Petrie, Keith J. ;
Main, Jodie ;
Weinman, John .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2006, 60 (06) :631-637
[3]   Sustained drug release by contact lenses for glaucoma treatment-A review [J].
Carvalho, I. M. ;
Marques, C. S. ;
Oliveira, R. S. ;
Coelho, P. B. ;
Costa, P. C. ;
Ferreira, D. C. .
JOURNAL OF CONTROLLED RELEASE, 2015, 202 :76-82
[4]   A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes [J].
Chan, Hiok Hong ;
Wong, Tina T. ;
Lamoureux, Ecosse ;
Perera, Shamira .
JOURNAL OF GLAUCOMA, 2015, 24 (07) :485-492
[5]   Patient Acceptance and Attitude Toward an Alternative Method of Subconjunctival Injection for the Medical Treatment of Glaucoma [J].
Chong, Rachel S. ;
Su, Daniel H. W. ;
Tsai, Andrew ;
Jiang, Yuzhen ;
Htoon, Hla Myint ;
Lamoureux, Ecosse L. ;
Aung, Tin ;
Wong, Tina T. .
JOURNAL OF GLAUCOMA, 2013, 22 (03) :190-194
[6]   In vivo performance of a drug-eluting contact lens to treat glaucoma for a month [J].
Ciolino, Joseph B. ;
Stefanescu, Cristina F. ;
Ross, Amy E. ;
Salvador-Culla, Borja ;
Cortez, Priscila ;
Ford, Eden M. ;
Wymbs, Kate A. ;
Sprague, Sarah L. ;
Mascoop, Daniel R. ;
Rudina, Shireen S. ;
Trauger, Sunia A. ;
Cade, Fabiano ;
Kohane, Daniel S. .
BIOMATERIALS, 2014, 35 (01) :432-439
[7]   Acceptance, Attitudes, and Beliefs of Singaporean Chinese Toward an Ocular Implant for Glaucoma Drug Delivery [J].
Foo, Reuben Chao Ming ;
Lamoureux, Ecosse L. ;
Wong, Ryan C. K. ;
Ho, Sue-Wei ;
Chiang, Peggy P. C. ;
Rees, Gwyneth ;
Aung, Tin ;
Wong, Tina T. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (13) :8240-8245
[8]   Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F2α-isopropyl ester treatment [J].
Gaton, DD ;
Sagara, T ;
Lindsey, JD ;
Gabelt, BT ;
Kaufman, PL ;
Weinreb, RN .
ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (08) :1165-1170
[9]   Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension [J].
Gazzard, Gus ;
Konstantakopoulou, Evgenia ;
Garway-Heath, David ;
Adeleke, Mariam ;
Vickerstaff, Victoria ;
Ambler, Gareth ;
Hunter, Rachael ;
Bunce, Catey ;
Nathwani, Neil ;
Barton, Keith ;
The LiGHT Trial Study Grp .
OPHTHALMOLOGY, 2023, 130 (02) :139-151
[10]   Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial [J].
Gazzard, Gus ;
Konstantakopoulou, Evgenia ;
Garway-Heath, David ;
Garg, Anurag ;
Vickerstaff, Victoria ;
Hunter, Rachael ;
Ambler, Gareth ;
Bunce, Catey ;
Wormald, Richard ;
Nathwani, Neil ;
Barton, Keith ;
Rubin, Gary ;
Buszewicz, Marta ;
Bourne, Rupert ;
Broadway, David ;
Bunce, Catey ;
Buszewicz, Marta ;
Davis, Amanda ;
Jayaram, Hari ;
Jiang, Yuzhen ;
Lim, Sheng ;
Liput, Joanna ;
Manners, Timothy ;
Morris, Stephen ;
Strouthidis, Nicholas ;
Wilson, Sarah ;
Wormald, Richard ;
Zhu, Haogang .
LANCET, 2019, 393 (10180) :1505-1516